UChicago Cancer Researchers Present at 2017 AACR Annual Meeting

Michelle Le Beau, AACR 2017

The Annual Meeting of the American Association of Cancer Research (AACR), the premier cancer research organization, brought together more than 21,000 scientists from across the globe in Washington, D.C. in early April to share their latest scientific breakthroughs. Our faculty and trainees made an exceptional showing at the conference, including the following highlights. A complete listing of UChicago presentations is here.

  • Nishant Agrawal, MD, professor of surgery, received the 2017 AACR Team Science Award as a member of the International Liquid Biopsy Initiative Team.
  • Yingming Zhao, PhD, professor in the Ben May Department of Cancer Research, presented his newly identified histone post-translational modifications, and efforts to identify their substrates, binding factors, and biological functions.
  • Thomas Gajewski, MD, PhD, professor of pathology, chaired a plenary session on immune-oncology biomarkers in clinical trials and presented his work on combination immunotherapy approaches through understanding the tumor, the host, and the microbiota, and tumor and host factors regulating immunotherapy responsiveness.
  • Lucy Godley, MD, PhD, associate professor of medicine, presented her work on control of cancer cell phenotypes by covalent cytosine modifications in a Meet-the-Expert session.
  • Melody Swartz, PhD, William B. Ogden Professor of Molecular Engineering, chaired and presented in a major symposium, specifically focusing her presentation on lymphatic transport of tumor-secreted exosomes and their implication on metastasis
  • Michelle Le Beau, PhD, Arthur and Marian Edelstein Professor of Medicine and director of the University of Chicago Medicine Comprehensive Cancer Center, chaired and presented in a professional advancement session on careers in clinical and translational research, and presented Mina Bissell, PhD, with the prestigious 14th AACR Award for Lifetime Achievement in Cancer Research.
  • Kay Macleod, PhD, associate professor in the Ben May Department for Cancer Research, presented her work on the mechanisms by which the autophagy regulator BNIP3 controls hepatocellular carcinoma growth.
  • Stefani Spranger, PhD, who recently became an assistant professor at MIT, presented her work from her postdoctoral fellowship with Dr. Gajewski on the mechanisms governing the induction and recruitment of antitumor effector T cells.
  • Postdoctoral fellow Peter Hart, PhD, from the laboratory of Iris Romero, MD, associate professor of obstetrics and gynecology, presented his work metformin-mediated effects on ovarian cancer cell invasion.
  • Faculty members Dezheng Huo, MD, PhD, Howard Halpern, MD, PhD, Ami Desai, MD, Brandon Pierce, PhD, David Grdina, PhD, Vassiliki Saloura, MD, and Jason Cheng, MD, PhD, presented posters on their latest research findings.

Tags: , , , ,

Related posts